PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity-Reference-Cited by-同舟云学术

PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity

Published:2016-05-18 Issue:5 Volume:6 Page:92
ISSN:2079-4991
Container-title:Nanomaterials
language:en
Short-container-title:Nanomaterials

Author:

De Rose Roberta,Cristiano Maria,Celano Marilena,Maggisano Valentina,Vero Ada,Lombardo Giovanni,Di Francesco Martina^ORCID,Paolino Donatella,Russo Diego,Cosco Donato

Publisher

MDPI AG

Subject

General Materials Science,General Chemical Engineering

Link

http://www.mdpi.com/2079-4991/6/5/92/pdf

Reference42 articles.

1. The Clinical and Economic Burden of a Sustained Increase in Thyroid Cancer Incidence

2. The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency ofBRAFMutations and a Sharp Increase inRASMutations

3. Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients

4. Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients

5. Correlation of Clinicopathological Features and Expression of Molecular Markers With Prognosis After 131I Treatment of Differentiated Thyroid Carcinoma

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The protective role of phosphodiesterase inhibitors in preventing colorectal cancer and advanced colorectal polyps: a systematic review and meta‐analysis;Colorectal Disease;2023-08-27

2. Intracellular cGMP increase is not involved in thyroid cancer cell death;PLOS ONE;2023-03-30

3. Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Tadalafil in Colorectal Cancer;Frontiers in Pharmacology;2022-05-27

4. How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme;Pharmacological Reports;2022-01-20

5. Hybrid chitosan-based nanoparticulate systems for drug delivery;Hybrid Nanomaterials for Drug Delivery;2022